Florida S0222 limits cost-sharing for insulin and diabetes devices to $35 and $100 respectively.
Florida S0222 establishes cost-sharing limits for diabetes management. It prohibits health insurance policies from imposing cost-sharing requirements exceeding $35 for a 30-day supply of insulin and $100 for a 30-day supply of any diabetes device or diabetic ketoacidosis device. This applies to all health insurance policies delivered, issued, renewed, or amended on or after January 1, 2027, for delivery to persons in Florida.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.